Is Enliven Therapeutics, Inc. technically bullish or bearish?

As of 26 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by bearish MACD readings on both weekly and monthly time frames, along with a mildly bearish indication from moving averages on the daily chart. The KST and OBV also reflect a mildly bearish trend on the weekly, while the Bollinger Bands show a sideways movement weekly and bearish monthly.
In terms of performance, the stock has underperformed against the S&P 500 over the past month, year-to-date, and year, with returns of -1.53%, -11.07%, and -17.04% respectively, while the S&P 500 has returned 2.75%, 12.96%, and 15.64% in those periods. However, it has significantly outperformed the benchmark over the 3-year period with a return of 848.34% compared to 81.77% for the S&P 500.